Position in SYRE
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$8,454,046
+$7,393,376 QoQ
Shares Held
167,606
+417.7% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
1.62%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
6 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in SYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STEMPOINT CAPITAL LP holds $493,288,963 across 62 Biotechnology names. SYRE ranks #20 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
1,035,496 | $50,904,983 | |
| 2 | ABVX |
Abivax S.A.
|
313,791 | $34,940,627 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
1,215,743 | $28,399,756 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
281,632 | $27,388,712 | |
| 5 | IMVT |
Immunovant, Inc.
|
746,494 | $18,542,910 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
56,267 | $18,128,664 | |
| 7 | SRZN |
Surrozen, Inc./DE
|
525,639 | $15,311,863 | |
| 8 | MBX |
MBX Biosciences, Inc.
|
499,469 | $14,909,149 |
All Filings in SYRE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,454,046 | 167,606 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,060,670 | 32,377 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,196,602 | 136,139 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $3,537,079 | 150,450 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,361,256 | 62,253 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $8,151,044 | 378,766 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||